Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Basket Study for Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction (RISE)

NCT06597682 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06597682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Basket Study for Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction (RISE)
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
July 31, 2027
Enrollment
632 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-acute sequelae of sars-cov-2 infection